Health Tip: After Liposuction (HealthDay News) -- Liposuction is a cosmetic procedure used to remove fat depos Health Tip: After Liposuction.
Depomed to borrow $15 million for hot flash drug Depomed will borrow $15 million from and to help pay for a hot flash treatment program.Menlo Park-based Depomed (NASDAQ: DEPO) is developing its drug Gabapentin GR to treat both neuropathic pain and menopausal hot flashes.
The...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis Neurocrine Biosciences, Inc.(NASDAQ:NBIX) announced today that the elagolix 0603 Phase Iib trial (Petal Study) has completed the 6-month treatment phase.
The last subject completed her Week 24 study visit in early June.
This Phase Iib...
Neurocrine completes treatment phase for endometriosis study The last subject completed her week 24 study visit in early June 2008.This Phase IIb trial (petal study) assesses the impact of elagolix treatment on bone mineral density as the primary endpoint using Dual Energy X-ray Absorptiometry (DXA...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis Study to Assess Impact of Elagolix on Bone Mineral Density SAN DIEGO, June 17, 2008 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.announced today that the elagolix 0603 Phase IIb trial (Petal Study) has completed the 6-month...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.NASDAQ: NBIX announced today that the elagolix 0603 Phase IIb trial (Petal Study) has completed the 6-month treatment phase.
The last subject completed her Week 24...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis STUDY TO ASSESS IMPACT OF ELAGOLIX ON BONE MINERAL DENSITY SAN DIEGO, June 17 SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.(Nasdaq: NBIX) announced today that the elagolix 0603 Phase IIb trial (Petal Study) has...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.(Nasdaq: NBIX) announced today that the elagolix 0603 Phase IIb trial (Petal Study) has completed the 6-month treatment phase.
The last subject completed her Week...
Sweet Adelines concert on June 14 to benefit the American Cancer Society The Oregon Coast Sweet Adeline Chorus will perform a benefit concert, Running in Harmony, June 14 at the Newport Performing Arts Center.(Courtesy photo) The Oregon Coast Sweet Adelines, under the direction of Carol Duvall, will perform at...
Anabolic Androgenic Steroid Use Pharmacology, Prevalence, and Psychiatric Aspects Check Points Public concern about the use of anabolic androgenic steroids by athletes and others has led to enhanced testing for these drugs as well as an improved understanding of their medical and psychiatric effects.This article reviews the...
Pfizer faces class-action lawsuit over Depo-Provera in Canada A Quebec Superior Court judge certified a national class-action lawsuit in which plaintiffs allege that Pfizer failed to provide adequate warning that women taking contraceptive Depo -Provera (medroxyprogesterone) may experience a loss...
Lawsuits against drug giants OK'd International drug companies Merck and Pfizer are facing two major class-action lawsuits in Canada, related to a once-popular pain relief medication and a widely used contraceptive.A Quebec Superior Court judge has approved a national...
Garden State Briefs Wall Street closed out a winning week with a narrowly mixed performance yesterday after the government reported that Americans' spending rose in April to keep pace with rising costs.Investors who sent stocks higher for three straight...
Class action certified against Pfizer - 09:45 EST Depo -Provera may cause a considerable reduction of bone mineral density MONTREAL (CNW) - A national class action has just been certified against Pfizer regarding its sales of Depo -Provera.Depo -Provera is a...
Class action certified against Pfizer Depo -Provera may cause a considerable reduction of bone mineral density MONTREAL, May 30 /CNW Telbec/ - A national class action has just been certified against Pfizer regarding its sales of Depo -Provera.Depo -Provera is a...
Class action certified against Pfizer Depo -Provera may cause a considerable reduction of bone mineral density MONTREAL, May 30 /CNW Telbec/ - A national class action has just been certified against Pfizer regarding its sales of Depo -Provera.Depo -Provera is a...
Que., Sask. courts approve class-action suits against 2 drug giants International drug companies Merck and Pfizer are facing two major class-action lawsuits in Canada, related to a once-popular pain relief medication and a widely used contraceptive.Saskatchewan's top court on Thursday approved a multi...
Drug giants face two Canadian class-action lawsuits Related Topics Story Tools -+ Change font size Share This Story Story tools presented by Henny Ray Abrams/Pharmaceutical giant Pfizer's New York headquarters International drug companies Merck and Pfizer are facing two major class-action...
Depomed to Present at the 7th Annual Needham & Co. Biotechnology & Medical Technology Conference Depomed, Inc.(DEPO) today announced that president and chief executive officer, Carl A.
Pelzel, will present on Thursday, June 12, 2008 at 10:00 a.m.
ET during the 7th Annual Needham & Company Biotechnology & Medical...
Que., Sask. courts approve class-action suits against 2 drug giants #bigbox{ width:320px; height:575px; float:right; margin:10px 0px 2px 2px; } International drug companies Merck and Pfizer are facing two major class-action lawsuits in Canada, related to a once-popular pain relief medication and a widely...
Two class-action lawsuits against drug giants approved in Canada Story Tools -+ Change font size Share This Story Story tools presented by Henny Ray Abrams/Pharmaceutical giant Pfizer's New York headquarters International drug companies Merck and Pfizer are facing two major class-action lawsuits in Canada...
Contraceptive class-action suit approved A Quebec Superior Court Justice has approved a class-action suit against pharmaceutical giant Pfizer Inc.and its subsidiary, Pfizer Canada Inc., by women who have taken the contraceptive Depo -Provera.
The drug, which is injected,...
Use of an IL-1 antagonist for treating arthritis Title: United States Patent: 7,361,350 Inventors: Mellis; Scott (New Rochelle, NY), Stahl; Neil (Carmel, NY), Radin; Allen (New York, NY), Weinstein; Steven (Hartsdale, NY), Calaprice; Denise (Nyack, NY), Karow; Margaret (Putnam Valley, NY),...
FDA Approves Mixject, a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's Trelstar Depo /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the U.S.
Food and Drug Administration has approved MIXJECT(TM), the new delivery system for TRELSTAR(R) ...
